Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights
Novavax (NVAX) concluded the recent trading session at $9.35, signifying a -1.16% move from its prior day's close.
NVAX - Novavax, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$18.00
DETAILS
HIGH:
$25.00
LOW:
$11.00
MEDIAN:
$18.00
CONSENSUS:
$18.00
UPSIDE:
93.86%
Stock News
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights
In the closing of the recent trading day, Novavax (NVAX) stood at $8.9, denoting a -1.17% move from the preceding trading day.
Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM
RALEIGH, N.C., June 24, 2026 (GLOBE NEWSWIRE) -- Shah Capital, the largest shareholder of Novavax, today commented on yesterday's announced voting results from Novavax's June 18th 2026 Annual Meeting of Stockholders.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know
Novavax (NVAX) closed the most recent trading day at $9.13, moving 3.89% from the previous trading session.
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is jumping again.
Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade
Novavax (NVAX) closed the most recent trading day at $8.88, moving 1.66% from the previous trading session.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax (NVAX) Up 10.4% Since Last Earnings Report: Can It Continue?
Novavax (NVAX) reported earnings 30 days ago. What's next for the stock?
Novavax, Inc. (NVAX) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Novavax, Inc. (NVAX) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Novavax to Participate in 2026 Jefferies Global Healthcare Conference
GAITHERSBURG, Md., June 1, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will participate in the 2026 Jefferies Global Healthcare Conference.
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Novavax, Inc. (NVAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Novavax, Inc. (NVAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally
The hantavirus isn't as contagious as the coronavirus, making a global pandemic unlikely. Picking the potential winners in the hantavirus vaccine market would hardly be worth the time and risk.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday's close of $54.35.
Hantavirus Scare Sparks Vaccine Stock Rally: Moderna, Novavax Climb
Moderna Inc. (NASDAQ:MRNA) and Novavax Inc. (NASDAQ:NVAX) shares moved higher Monday as traders piled back into vaccine names following renewed concerns over a hantavirus outbreak tied to the MV Hondius cruise ship.
Hantavirus cases spark surge in pharma and biotech stocks — here's why
Several pharmaceutical stocks are rising in premarket trading in the wake of a hantavirus outbreak. Moderna, Inovio, Novavax, and Emergent Biosolutions rose in early market trading.
What's Going On With Novavax Stock On Friday?
Novavax Inc. (NASDAQ:NVAX) stock is trading higher on Friday in reaction to a surge in Moderna Inc. (NASDAQ:MRNA).
Price Targets
Novavax initiated with an Overweight at Cantor Fitzgerald
$18.00
(was $8.55)
Cantor Fitzgerald
Novavax price target raised to $11 from $10 at H.C. Wainwright
$11.00
(was $8.46)
Sean Lee
·
H.C. Wainwright
Novavax (NVAX) PT Lowered to $22 at B.Riley
$22.00
(was $7.58)
Mayank Mamtani
·
B.Riley Financial
Novavax (NVAX) PT Lowered to $25 at Jefferies
$25.00
(was $10.15)
Roger Song
·
Jefferies
Novavax (NVAX) PT Lowered to $14 at BofA Securities 'to reflect delays in phase 3 CIC/standalone flu trial'
$14.00
(was $10.45)
Alec Stranahan
·
Bank of America Securities
Novavax price target lowered to $31 from $38 at Jefferies
$31.00
(was $14.36)
Roger Song
·
Jefferies
H.C. Wainwright reiterates Buy rating on Novavax after 'landmark' Sanofi deal
$19.00
(was $9.94)
Vernon Bernardino
·
H.C. Wainwright
Novavax (NVAX) Stock: $174 Price Target From Cantor Fitzgerald
$174.00
(was $80.11)
Charles Duncan
·
Cantor Fitzgerald